No Data
No Data
ExtraordinAri Gems Introduces Exclusive Jewelry Honoring the 2025 U.S. Equestrian Open
Ozempic (Semaglutide) Injection 1 Mg Showed Improved Functional Outcomes and Health-related Quality of Life in Phase 3 STRIDE Trial in Adults With Type 2 Diabetes and Peripheral Artery Disease (PAD) Presented at ACC 2025
Actis Buys Stride Climate Investments From Macquarie Asset Management
VensureHR and MedCerts, a Stride, Inc. Company, Partner to Address Healthcare Staffing Challenges
LRN Wins Best Regulatory, Governance, and Compliance Technology at Legalweek 2025
K12 Tutoring Partners With Lake Forest School District to Provide High-Impact Tutoring After Tutoring Provider Closure